Last crusade against HCV: Direct-acting antiviral treatment for marginalized populations

Affiliations

¹ Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
² Department of Internal Medicine, Osaka Socio-Medical Center Hospital, Osaka, Japan.
³ Department of Molecular Pathology, Tokyo Medical University, Kyoto, Japan.

Comment

Hideki Fujii et al. J Viral Hepat. 2019 Dec.

. 2019 Dec;26(12):1501.

doi: 10.1111/jvh.13190. Epub 2019 Oct 2.

¹ Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan.
² Department of Internal Medicine, Osaka Socio-Medical Center Hospital, Osaka, Japan.
³ Department of Molecular Pathology, Tokyo Medical University, Kyoto, Japan.

No abstract available

Comment on

Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
Bajis S, Grebely J, Cooper L, Smith J, Owen G, Chudleigh A, Hajarizadeh B, Martinello M, Adey S, Read P, Gilliver R, Applegate T, Treloar C, Maher L, Dore GJ. Bajis S, et al. J Viral Hepat. 2019 Aug;26(8):969-979. doi: 10.1111/jvh.13112. Epub 2019 May 2. J Viral Hepat. 2019. PMID: 30980785